How to translate a Treg cell research workflow to clinical-grade manufacturing

Presented By:
Niloufar Monhasery

Speaker Biography:
Niloufar Monhasery received her PhD in Biology from the University of Düsseldorf (Germany) in 2016. She then continued her studies in Cancer Research as a Postdoctoral Fellow at the Princess Margaret Cancer Center in Toronto (Canada) and the University Hospital Cologne (Germany). In 2019, she joined Miltenyi Biotec as a Global Product Manager for T cell Immunology.

Webinar:
How to translate a Treg cell research workflow to clinical-grade manufacturing

Webinar Abstract:
The unique suppressive function of regulatory T cells (Treg cells) makes them an interesting target cell population to study. In recent years, translation of Treg cell research to the clinical setting was one of the main challenges in the Treg field. Miltenyi Biotec offers comprehensive solutions for each step of your Treg cell research and clinical workflows to make your research truly translational.

Earn PACE Credits:

LabRoots on Social:
SnapChat: labroots_inc